Skip to main content
Palgrave Macmillan

Emerging Technologies for Diagnosing Alzheimer's Disease

Innovating with Care

  • Book
  • © 2016

Overview

Part of the book series: Health, Technology and Society (HTE)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

  1. Diagnosing Alzheimer’s Disease: Current Practices

  2. Assessing Diagnostic Innovations

Keywords

About this book

This book explores international biomedical research and development on the early diagnosis of Alzheimer's disease. It offers timely, multidisciplinary reflections on the social and ethical issues raised by promises of early diagnostics and asks under which conditions emerging diagnostic technologies can be considered a responsible innovation. 


The initial chapters in this edited volume provide an overview and a critical discussion of recent developments in biomedical research on Alzheimer's disease. Subsequent contributions explore the values at stake in current practices of dealing with Alzheimer's disease and dementia, both within and outside the biomedical domain. Novel diagnostic technologies for Alzheimer's disease emerge in a complex and shifting field, full of controversies. Innovating with care requires a precise mapping of how concepts, values and responsibilities are filled in through the confrontation of practices. In doing so, the volumeoffers a practice-based approach of responsible innovation that is also applicable to other fields of innovation. 


Reviews

“This seamless set of engaging and thoughtful essays examines how and why we’ve arrived at a multi-national and multi-million dollar effort to remake Alzheimer’s disease using biomarkers, events that are part of a larger story of biomedicine’s effort to become a “precision medicine” that will categorize, explain and take care of not only the problem of older adults with cognitive impairments but the chronic diseases of aging. Readers will discover how Alzheimer’s disease, a disease we say is so common and costly, remains so elusive to measurement, coherent public policy and dignified care.” (Jason Karlawish, Professor of Medicine, Medical Ethics and Health Policy, and Neurology, University of Pennsylvania, USA)

“This remarkable volume about technological innovation in the Alzheimer world should be read by all involved physicians, researchers, patients and their families, and the public at large. In fourteen even-handed, thought-provoking chapters that create a sum greater than their parts, the perceived consequences of a shift to an early diagnosis of AD through biomarker detection are discussed in depth. Readers learn that AD is a poorly delineated phenomenon -- a multi-form syndrome in which disjunctions between assumed pathology and clinical manifestations are common. Nevertheless, “responsible innovation” can be achieved.” (Margaret Lock PhD, The Alzheimer’s Conundrum, Princeton University Press)

Editors and Affiliations

  • Department of Philosophy, University of Twente, The Netherlands, Enschede, The Netherlands

    Marianne Boenink

  • Faculty of Arts and Social Sciences, University of Maastricht, The Netherlands, Maastricht, The Netherlands

    Harro van Lente

  • Utrecht University, The Netherlands, Utrecht, The Netherlands

    Ellen Moors

About the editors

Marianne Boenink is Assistant Professor at the Department of Philosophy, University of Twente, The Netherlands. Her research focuses on the philosophical and ethical issues posed by emerging biomedical technologies. She has published on the ethics of predictive testing, concepts of disease in molecular medicine, and methods for ethics of emerging technologies. 


Harro van Lente is Full Professor of Science and Technology Studies at Maastricht University, The Netherlands. He was trained in physics and philosophy and he studies the dynamics of emerging technologies. He has published widely on the sociology of expectations, technology assessment, foresight, sustainability and the politics of knowledge production. 


Ellen Moors is Full Professor of Sustainable Innovation at the Copernicus Institute of Sustainable Development, Utrecht University, The Netherlands. Her research focuses on technology dynamics and governance of lifesciences innovations, the role of users and institutions in emerging technologies, and sustainable or responsible health innovation business models.


Bibliographic Information

Publish with us